Mycobiome

BIOHM Partners with Life Extension to Bring DataMap Innovation to Life Extension Customer Base

Retrieved on: 
Tuesday, March 7, 2023

CLEVELAND, March 7, 2023 /PRNewswire/ -- BIOHM Health Inc., a renowned microbiome innovation company, announced today that it has partnered with the science-focused health and wellness brand Life Extension to discover and launch a new line of supplements, powered by BIOHM's DataMap platform and tailored to the needs of Life Extension's customer base. This collaboration enables Life Extension to leverage BIOHM's microbiome data platform to design highly targeted microbiome supplements for its consumers.

Key Points: 
  • This collaboration enables Life Extension to leverage BIOHM's microbiome data platform to design highly targeted microbiome supplements for its consumers.
  • "We're proud to partner with Life Extension to create a breakthrough line of microbiome products specifically developed for their consumers," said BIOHM Health CEO, Afif Ghannoum.
  • This type of product development is game-changing for partners looking to bring best-in-class products to their customers and we're thrilled that Life Extension has joined us in this mission."
  • "BIOHM and Life Extension are both science-driven companies with a deep commitment to innovation and improving health," said Life Extension's Chief Scientific Officer, Dr. Andrew G. Swick, PhD.

Micronoma to Provide Oncobiota Solution and Company Updates During JPM Life Science Conference Week 2023

Retrieved on: 
Wednesday, December 14, 2022

Micronoma , the first biotech company offering early cancer detection using a microbiome-driven liquid biopsy platform, today announced that Sandrine Miller-Montgomery, Ph.D., Pharm.D., CEO and Co-founder of Micronoma will participate in J.P. Morgan Week in San Francisco, CA in January 2023.

Key Points: 
  • Micronoma , the first biotech company offering early cancer detection using a microbiome-driven liquid biopsy platform, today announced that Sandrine Miller-Montgomery, Ph.D., Pharm.D., CEO and Co-founder of Micronoma will participate in J.P. Morgan Week in San Francisco, CA in January 2023.
  • Miller-Montgomery will present company updates at the following events:
    At these events, Miller-Montgomery will engage with registered investors, global biotech companies and potential strategic partners introducing and updating Micronoma's innovations and future product launch.
  • Micronomas patent-pending Oncobiota platform is designed to reveal cancer-related microbiome biomarkers in the earliest stages (stages I and II).
  • Diagnostic assays for liver, pancreatic, and ovarian cancers are also in the Micronoma pipeline.

Newly Released Data Ranks States with the Most Bloated, Gassy, and Constipated People - and More!

Retrieved on: 
Tuesday, November 15, 2022

CLEVELAND, Nov. 15, 2022 /PRNewswire/ -- BIOHM, the company co-founded by the renowned scientist who named the mycobiome, Dr. Mahmoud Ghannoum, is releasing data related to the voluntary "Gut Quiz," hosted on their site to help guide individuals on lifestyle, diet, and supplement decisions. From a sample of 35,000 individuals across the U.S., trends are appearing by regions and states based on constipation, gas, bloating, Candida diagnoses, and antibiotic use. A full list rankings can be found HERE. 

Key Points: 
  • From a sample of 35,000 individuals across the U.S., trends are appearing by regions and states based on constipation, gas, bloating, Candida diagnoses, and antibiotic use.
  • States with the highest bloating statistics include Vermont with 74% of participating residents reporting bloat symptoms, followed Nevada by Arizona with 71% reporting bloat.
  • Mississippi ranks number one in Candida diagnoses, with 12% reporting Candida, followed by Kansas and New Mexico both at 11%.
  • BIOHM is one of the world's leading microbiome companies utilizing microbiome data to empower individuals to live healthier lives.

Solarea Bio Investigators Receive National Academy of Medicine Healthy Longevity 2022 Quickfire Challenge Award

Retrieved on: 
Thursday, September 29, 2022

CAMBRIDGE, Mass., Sept. 29, 2022 /PRNewswire/ -- Solarea Bio, a clinical stage biotech company, has been selected as an awardee of the NAM Healthy Longevity 2022 QuickFire Challenge, launched by Johnson & Johnson Innovation together with the National Academy of Medicine, for work studying the mycobiome as a novel class of probiotics to target inflammation associated with aging, or 'inflammaging'.  

Key Points: 
  • CAMBRIDGE, Mass., Sept. 29, 2022 /PRNewswire/ -- Solarea Bio , a clinical stage biotech company, has been selected as an awardee of the NAM Healthy Longevity 2022 QuickFire Challenge, launched by Johnson & Johnson Innovation together with the National Academy of Medicine, for work studying the mycobiome as a novel class of probiotics to target inflammation associated with aging, or 'inflammaging'.
  • With inflammation as its core target, Solarea is developing a pipeline of products in addition to its existing lead clinical program for the dietary management of bone health.
  • Dr. Eric Schott, co-founder and Vice President of Translational Research and Operations at Solarea said, "Healthy aging as a target is advancing through the product development process with strong initial results.
  • The National Academy of Medicine's Healthy Longevity Initiative is designed to kick start innovation to support healthy longevity through a series of monetary awards and prizes.

BIOHM Launches World-Class Suite of Services for Microbiome Leaders, Including Product Development, Bioinformatics, Testing and Clinical Trial Support

Retrieved on: 
Wednesday, August 31, 2022

CLEVELAND, Aug. 31, 2022 /PRNewswire/ -- BIOHM, the leading microbiome company guided by the cutting-edge science of Dr. Mahmoud Ghannoum, is launching a suite of services for microbiome innovators. With established state-of-the-art laboratories and one of the largest microbiome datasets in the world that combines bacterial and fungal sequencing, BIOHM offers turnkey partnership opportunities in ingredient formulation, bioinformatics, testing, and clinical trial support.

Key Points: 
  • With established state-of-the-art laboratories and one of the largest microbiome datasets in the world that combines bacterial and fungal sequencing, BIOHM offers turnkey partnership opportunities in ingredient formulation, bioinformatics, testing, and clinical trial support.
  • "At BIOHM, we felt a responsibility to create access to the most current, comprehensive, and clinically studied microbiome data available.
  • The three services offered by BIOHM include:
    BIOHM offers Microbiome Ingredients and Products, from turnkey ingredients and formulations to cohort selection and postbiotic development.
  • BIOHM is one of the world's leading microbiome companies utilizing microbiome data to empower individuals to live healthier lives.

­­­Review in Chinese Medical Journal Explores Effect of Gut Microbiota on Inflammatory Bowel Disease

Retrieved on: 
Tuesday, January 18, 2022

"Dysbiosis" or an imbalance in their populations can, however, contribute to the pathology of gastrointestinal diseases such as inflammatory bowel disease (IBD).

Key Points: 
  • "Dysbiosis" or an imbalance in their populations can, however, contribute to the pathology of gastrointestinal diseases such as inflammatory bowel disease (IBD).
  • Researchers from the Peking Union Medical College, China and the Chinese Academy of Medical Sciences have delved deeper into understanding multi-dimensional dysbiosis and technologies that can aid the diagnosis and treatment of IBD.
  • Next, they describe the "mycobiome" or fungal microbiota, that has been relatively less explored, and their interplay with bacterial populations.
  • Finally, the review highlights therapeutic strategies such as "fetal microbiota transplantation" and "supplementary probiotics" that can help replenish gut microbiota and restore balance.

Solarea Bio Teams up with Hebrew SeniorLife Investigators on a Newly Awarded U.S. National Academy of Medicine Catalyst Grant

Retrieved on: 
Thursday, November 4, 2021

Solarea Bio, along with Douglas P. Kiel, M.D., M.P.H., Director, Musculoskeletal Research Center, Hinda and Arthur Marcus Institute for Aging Research, and Shivani Sahni, Ph.D., Director, Nutrition Program, Marcus Institute, received the grant.

Key Points: 
  • Solarea Bio, along with Douglas P. Kiel, M.D., M.P.H., Director, Musculoskeletal Research Center, Hinda and Arthur Marcus Institute for Aging Research, and Shivani Sahni, Ph.D., Director, Nutrition Program, Marcus Institute, received the grant.
  • Hebrew SeniorLife, an affiliate of Harvard Medical School, is a national senior services leader uniquely dedicated to rethinking, researching, and redefining the possibilities of aging.
  • Hebrew SeniorLife cares for more than 3,000 seniors a day across six campuses throughout Greater Boston.
  • For more information about Hebrew SeniorLife, visit https://www.hebrewseniorlife.org or follow us on our blog , Facebook , Instagram , Twitter , and LinkedIn .